Home Mechanical Ventilation, Neuromuscular Disease
Conditions
Keywords
nocturnal hypoventilation, capno-oxymetry
Brief summary
Different tools may be used to monitor the efficacy of home mechanical ventilation. Investigators aimed to compare the prognostic value of the different data obtained by capno-oxymetry in a mechanical ventilated neuromuscular disease's population.
Detailed description
Home mechanical ventilation (HMV) is used to treat hypoventilation, and its efficacy is mostly assessed by daytime blood gases and nocturnal oxymetry (SpO2). Transcutaneous CO2 measure (TcCO2) has shown higher sensitivity than SpO2 to detect hypoventilation in neuromuscular diseases (NMD) patients. No data exist on the prognostic value of these techniques to monitor mechanical ventilated NMD patients. Basing on retrospective data review, investigators aimed to compare the prognostic value of the data obtained using different tools to assess residual hypoventilation in the cohort of ventilated NMD patients followed at our reference center.
Interventions
DEVICECapno-oxymetry monitoring
Monitoring of home mechanical ventilation by capno-oximetry
Sponsors
Centre d'Investigation Clinique et Technologique 805
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* neuromuscular disease * age ≥18 years * mechanically ventilated * capno-oxymetry performed between 2009 and 2011
Exclusion criteria
* Long-term oxygen therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to first ICU admission | 6 years | Time to first ICU admission |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 6 years | Time to death |
Countries
France
Outcome results
None listed